Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Immune System Diseases × Plasmalyte A × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Immune System Diseases 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 4 Tacrolimus 4 Mycophenolic Acid 4 Busulfan 4 pembrolizumab 2 fludarabine 2 cobomarsen 2 Whole-Body Irradiation 2 Vincristine 2 Rituximab 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Doxorubicin 2 thymoglobulin 1 Vorinostat 1 Plasmalyte A 1 Ifosfamide 1 Etoposide 1 Dimethyl Sulfoxide 1 Carboplatin 1 Brentuximab Vedotin 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02519816 2019-08-14

CARE

Maisonneuve-Rosemont Hospital

Phase 2 Unknown

Immune System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡